Rating History for Exelixis (exel) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/10/2023 | Joseph Catanzaro | New Coverage | Overweight (N/A) |
28.00 (N/A) |
19.03 (23.61) |
24.07% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/10/2023 | Joseph Catanzaro | New Coverage | Overweight (N/A) |
28.00 (N/A) |
19.03 (23.61) |
24.07% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
